192 related articles for article (PubMed ID: 24202334)
1. Immune regulatory activity of vitamin d3 in head and neck cancer.
Young MR; Day TA
Cancers (Basel); 2013 Aug; 5(3):1072-85. PubMed ID: 24202334
[TBL] [Abstract][Full Text] [Related]
2. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
[TBL] [Abstract][Full Text] [Related]
3. Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers.
Young MR; Lathers DM
Int J Immunopharmacol; 1999 Apr; 21(4):241-52. PubMed ID: 10408632
[TBL] [Abstract][Full Text] [Related]
4. Protective mechanisms of head and neck squamous cell carcinomas from immune assault.
Young MR
Head Neck; 2006 May; 28(5):462-70. PubMed ID: 16284974
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for head and neck cancer: advances and deficiencies.
De Costa AM; Young MR
Anticancer Drugs; 2011 Aug; 22(7):674-81. PubMed ID: 21037467
[TBL] [Abstract][Full Text] [Related]
6. [Vitamin D in relation to head and neck cancer].
Kalfeřt D; Ludvíková M; Pešta M; Topolčan O
Vnitr Lek; 2014 Jan; 60(1):51-8. PubMed ID: 24564776
[TBL] [Abstract][Full Text] [Related]
7. Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma.
Seliger B; Massa C; Yang B; Bethmann D; Kappler M; Eckert AW; Wickenhauser C
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987799
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
[TBL] [Abstract][Full Text] [Related]
9. The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial.
Weed DT; Zilio S; Reis IM; Sargi Z; Abouyared M; Gomez-Fernandez CR; Civantos FJ; Rodriguez CP; Serafini P
Front Immunol; 2019; 10():1206. PubMed ID: 31214178
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
11. Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers.
Suzuki S; Ogawa T; Sano R; Takahara T; Inukai D; Akira S; Tsuchida H; Yoshikawa K; Ueda R; Tsuzuki T
Cancer Sci; 2020 Jun; 111(6):1943-1957. PubMed ID: 32304268
[TBL] [Abstract][Full Text] [Related]
12. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
Solomon B; Young RJ; Rischin D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs.
Hager G; Kornfehl J; Knerer B; Weigel G; Formanek M
Acta Otolaryngol; 2004 Jan; 124(1):90-6. PubMed ID: 14977084
[TBL] [Abstract][Full Text] [Related]
14. Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.
Walsh JE; Clark AM; Day TA; Gillespie MB; Young MR
Hum Immunol; 2010 Jul; 71(7):659-65. PubMed ID: 20438786
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy for the treatment of head and neck cancer.
Karam SD; Raben D
Lancet Oncol; 2019 Aug; 20(8):e404-e416. PubMed ID: 31364593
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.
Maggioni D; Pignataro L; Garavello W
Oncoimmunology; 2017; 6(7):e1325066. PubMed ID: 28811959
[TBL] [Abstract][Full Text] [Related]
18. Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy.
Gameiro SF; Ghasemi F; Barrett JW; Koropatnick J; Nichols AC; Mymryk JS; Maleki Vareki S
Oncoimmunology; 2018; 7(10):e1498439. PubMed ID: 30288365
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.
Özcan-Wahlbrink M; Schifflers C; Riemer AB
Front Immunol; 2019; 10():2831. PubMed ID: 31849993
[TBL] [Abstract][Full Text] [Related]
20. Correlate the
Lyu H; Li M; Jiang Z; Liu Z; Wang X
Comput Struct Biotechnol J; 2019; 17():1020-1030. PubMed ID: 31428295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
